We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$1.02B
AUM Growth
+$5.4M
Cap. Flow
-$164M
Cap. Flow %
-16.09%
Top 10 Hldgs %
38.61%
Holding
122
New
34
Increased
17
Reduced
32
Closed
31

Top Buys

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$17.8M
2
NVDA icon
NVIDIA
NVDA
+$15.9M
3
CEG icon
Constellation Energy
CEG
+$13.4M
4
TSM icon
TSMC
TSM
+$12.1M
5
AAPL icon
Apple
AAPL
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 29.18%
2 Healthcare 26.79%
3 Consumer Discretionary 8.41%
4 Industrials 8.14%
5 Communication Services 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELAN icon
76
Elanco Animal Health
ELAN
$12.1B
$2.94M 0.29%
203,985
-223,203
-52% -$3.57M
KYMR icon
77
Kymera Therapeutics
KYMR
$8.85B
$2.75M 0.27%
92,000
-10,000
-10% -$346K
DUOL icon
78
Duolingo
DUOL
$5.74B
$2.73M 0.27%
13,068
-25,932
-66% -$5.31M
MPT
79
PUT
Medical Properties Trust
MPT
$2.75B
$2.59M 0.25%
6,000
INSM icon
80
Insmed
INSM
$28.9B
$2.41M 0.24%
+36,000
New +$1.4M
ABVX
81
Abivax
ABVX
$11.3B
$2.26M 0.22%
170,637
+120,644
+241% +$1.73M
RPD icon
82
PUT
Rapid7
RPD
$694M
$2.23M 0.22%
+515
New +$21.5K
FIVN icon
83
CALL
FIVE9
FIVN
$2.17B
$2.08M 0.2%
+472
New +$24.5K
ONON icon
84
PUT
On Holding
ONON
$12.4B
$1.94M 0.19%
+500
New +$18.3K
COHR icon
85
Coherent
COHR
$65.4B
$1.52M 0.15%
21,000
-99,000
-83% -$5.95M
CATX icon
86
Perspective Therapeutics
CATX
$339M
$1.42M 0.14%
+142,499
New +$2.06M
ATRC icon
87
PUT
AtriCure
ATRC
$2.01B
$1.32M 0.13%
+580
New +$13.4K
RH icon
88
RH
RH
$3.56B
$978K 0.1%
4,000
-13,500
-77% -$3.55M
IMNM icon
89
Immunome
IMNM
$2.92B
$895K 0.09%
74,000
-241,000
-77% -$3.77M
CABA icon
90
CALL
Cabaletta Bio
CABA
$450M
$748K 0.07%
1,000
RIVN icon
91
Rivian
RIVN
$22.3B
$268K 0.03%
+20,000
New +$209K
AMD icon
92
Advanced Micro Devices
AMD
$799B
-66,000
Closed -$11.9M
ASND icon
93
Ascendis Pharma A/S
ASND
$16.4B
-48,500
Closed -$7.33M
BHVN icon
94
Biohaven
BHVN
$2.17B
-37,500
Closed -$2.05M
CELH icon
95
Celsius Holdings
CELH
$6.08B
-120,000
Closed -$9.95M
CP icon
96
Canadian Pacific Kansas City
CP
$79.3B
-63,000
Closed -$5.55M
CRSP icon
97
CRISPR Therapeutics
CRSP
$4.99B
-48,000
Closed -$3.27M
CRWD icon
98
CrowdStrike
CRWD
$211B
-98,000
Closed -$7.85M
CYTK icon
99
Cytokinetics
CYTK
$11B
-70,000
Closed -$4.91M
ESTA icon
100
PUT
Establishment Labs
ESTA
$2.33B
-2,409
Closed -$12.3M

Similar funds

Atika Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Atika Capital Management held 122 positions worth $1.02B, up 0.53% from $1.02B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Atika Capital Management withdrew a net $164M in Q2 2024, closing 31 positions and reducing 32 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $37.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Atika Capital Management opened a new position in Spotify worth $18.5M.

  • Atika Capital Management's largest Q2 2024 buy was Spotify: 59,000 shares worth $18.5M.
  • Atika Capital Management added most to NVIDIA in Q2 2024, an estimated $15.9M increase.
  • Atika Capital Management's biggest Q2 2024 reduction was monday.com, cutting an estimated $9.7M.
  • Atika Capital Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $37.3M.
  • Atika Capital Management's ten largest holdings make up 39% of its $1.02B portfolio in Q2 2024.
  • Atika Capital Management opened 34 new positions and closed 31 in Q2 2024.
  • Atika Capital Management's portfolio value rose 0.53% quarter-over-quarter to $1.02B.

Based on Atika Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.